{"gene":"FXN","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2009,"finding":"Bacterial frataxin ortholog CyaY acts as an iron-dependent inhibitor of iron-sulfur (Fe-S) cluster formation by binding to the desulfurase IscS through its iron-binding surface, functioning as an iron sensor/regulator that fine-tunes Fe-S cluster assembly relative to available acceptor concentration.","method":"Biochemical and biophysical assays (iron-dependent binding to IscS, kinetic measurements of cluster formation, site-directed analysis of iron-binding surface)","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical and biophysical methods in a focused mechanistic study; binding to IscS directly demonstrated and inhibitory mechanism characterized","pmids":["19305405"],"is_preprint":false},{"year":2000,"finding":"The crystal structure of E. coli frataxin ortholog CyaY was solved at 1.4 Å resolution, revealing a novel fold consisting of a six-stranded antiparallel β-sheet flanked by two α-helices, predicted to be shared by all frataxin family members and providing a framework for interpreting disease-associated mutations.","method":"X-ray crystallography (1.4 Å resolution)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure determination with clear functional interpretation; foundational structural result","pmids":["10908679"],"is_preprint":false},{"year":2004,"finding":"CyaY (bacterial frataxin ortholog) binds at least two ferrous ions per monomer with weak affinity (Kd ~4 µM), consistent with an iron chaperone role; Fe(II) is oxidized rapidly by H2O2 (not O2) with stoichiometry of 2 Fe(II)/H2O2, greatly attenuating hydroxyl radical production from Fenton chemistry; up to ~25–26 Fe(III) ions can bind per monomer, and iron addition induces tetramerization.","method":"Isothermal titration calorimetry (ITC), EPR spin trapping, UV-visible/fluorescence spectroscopy, iron analysis, pH-stat titrations, analytical ultracentrifugation","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro methods in a single rigorous study measuring binding stoichiometry, oxidation kinetics, and oligomerization","pmids":["15276847"],"is_preprint":false},{"year":2004,"finding":"The solution structure of CyaY was solved by NMR; iron binding was mapped to a highly anionic surface of the molecule (conserved across frataxin family) that hosts both Fe(2+) and Fe(3+) with defined stoichiometry without requiring aggregation; secondary binding sites on CyaY (absent in human frataxin) may underlie its polymerization mechanism.","method":"NMR structure determination, mutagenesis of iron-binding surface, comparative binding studies with wild-type vs. mutant CyaY","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure plus mutagenesis functional validation; single lab but multiple orthogonal approaches","pmids":["15530368"],"is_preprint":false},{"year":2011,"finding":"CyaY slows down Fe-S cluster formation on the IscU scaffold protein and does not alter the relative ratio of [2Fe2S]²⁺ to [4Fe4S]²⁺ clusters but directly affects the enzymatic activity of IscS, independently confirming an inhibitory rather than activating role for the bacterial frataxin ortholog.","method":"Spectroscopic characterization of cluster formation kinetics (UV-vis, resonance Raman, EPR, Mössbauer), enzymatic assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple spectroscopic methods independently confirming CyaY inhibitory mechanism on IscS/IscU system","pmids":["21799759"],"is_preprint":false},{"year":2001,"finding":"Frataxin expression in Friedreich's ataxia lymphoblasts rescues mitochondrial iron homeostasis and membrane potential defects: FXN-deficient cells showed increased filtrable mitochondrial iron, decreased mitochondrial membrane potential (MMP), and reduced aconitase/ICDH activities, all of which were reversed by transfection of frataxin to near-physiological levels, establishing frataxin's direct role in mitochondrial iron homeostasis and protection from oxidative stress.","method":"Stable transfection of frataxin into FRDA compound heterozygote lymphoblasts, mitochondrial iron measurement, MMP measurement, aconitase/ICDH enzyme assays, oxidative stress challenge","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean rescue/complementation experiment with multiple orthogonal functional readouts; direct mechanistic placement of frataxin in mitochondrial iron homeostasis","pmids":["11590127"],"is_preprint":false},{"year":2015,"finding":"CyaY is a member of the ISC pathway for Fe-S cluster protein maturation in E. coli, requiring iron-rich conditions for its contribution; a genetic interaction was discovered between cyaY and iscX (additive effect on Fe-S cluster maturation when both genes are deleted), establishing IscX as a co-regulator.","method":"Genetic knockout/double knockout, in vivo Fe-S cluster protein activity assays, growth phenotype analysis under iron-variable conditions","journal":"Molecular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple phenotypic readouts, single lab","pmids":["25430730"],"is_preprint":false},{"year":2018,"finding":"IscX (YfhJ) competes with CyaY for the same binding surface on IscS; at low iron concentrations IscX rescues the CyaY-inhibited rate of enzymatic Fe-S cluster formation, while at high iron the competition effect is negligible, establishing a dual iron-concentration-dependent regulatory mechanism of Fe-S cluster assembly mediated by the CyaY/IscX competition.","method":"NMR, small-angle X-ray scattering (SAXS), biochemical competition assays, kinetic measurements of cluster assembly","journal":"Frontiers in molecular biosciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural (NMR/SAXS) plus biochemical competition assays demonstrating mechanism, single lab with multiple orthogonal methods","pmids":["29457004"],"is_preprint":false},{"year":1999,"finding":"Knockout of cyaY in E. coli did not affect cellular iron content or sensitivity to oxidants under normal conditions, suggesting that despite structural similarities CyaY may have a different or redundant function compared to mitochondrial frataxin homologs in eukaryotes.","method":"Homologous recombination knockout, iron content measurement, H2O2 sensitivity assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean loss-of-function experiment with defined readouts, single lab; negative result mechanistically informative (functional redundancy in bacteria)","pmids":["10452520"],"is_preprint":false},{"year":2007,"finding":"CyaY (frataxin ortholog) expressed as a mitochondria-targeted form in S. cerevisiae yfh1Δ complemented loss of Fe-S cluster enzyme activities and heme synthesis, maintaining near-normal respiratory growth and protecting against oxidative damage, demonstrating partial conservation of frataxin function between prokaryotes and eukaryotes.","method":"Mitochondria-targeted expression of CyaY in frataxin-null yeast, respiratory growth assays, Fe-S enzyme activity measurements, oxidative stress assays","journal":"FEMS yeast research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic complementation with multiple functional assays; demonstrates functional conservation and iron/Fe-S role","pmids":["17727661"],"is_preprint":false},{"year":2007,"finding":"Deletion of cyaY in E. coli reduces the amount of assembled respiratory complex I (NADH:ubiquinone oxidoreductase) by one third, but the assembled complex retains full activity and all iron-sulfur clusters; live-cell GFP imaging and fractionation showed CyaY localizes to the cytoplasm, not the membrane, establishing a non-essential assembly role rather than structural component role.","method":"cyaY deletion mutant analysis, Western blot, live-cell GFP imaging, subcellular fractionation, complex I activity assay","journal":"BMC biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment combined with loss-of-function and biochemical characterization, single lab","pmids":["17650323"],"is_preprint":false},{"year":2011,"finding":"Expanded GAA repeats in FXN intron 1 induce heterochromatin-like histone modifications downstream of the promoter (near the GAA tract) and impede the transition from transcription initiation to productive elongation; pre-mRNA levels upstream of the GAA repeats were similar in FRDA and control cells, establishing that the primary block is at post-initiation/elongation, not initiation.","method":"Chromatin immunoprecipitation (ChIP) with quantitative PCR, GFP reporter assay with 560 GAA repeats, pre-mRNA quantification by qPCR","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — orthogonal ChIP and reporter assays with quantitative controls; independently consistent results across patient cells and reporter model","pmids":["21745819"],"is_preprint":false},{"year":2015,"finding":"Expanded GAA repeats impede transcription elongation through the FXN locus without affecting neighboring genes; deep sequencing of FXN pre-mRNA revealed a pronounced elongation defect in FRDA cells; ChIP studies confirmed heterochromatin histone marks are confined to the FXN locus and not spread to flanking genomic regions.","method":"Next-generation RNA sequencing of FRDA and control fibroblasts, FXN pre-mRNA deep sequencing, ChIP with histone modification antibodies","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — large cohort RNA-seq with orthogonal ChIP studies confirming locus-restricted silencing and elongation defect","pmids":["26401053"],"is_preprint":false},{"year":2003,"finding":"Frataxin-EGFP fusion proteins are targeted to mitochondria when driven by the endogenous FRDA locus regulatory elements; hemin and butyric acid enhance FRDA gene expression from the intact locus, establishing that FXN expression can be pharmacologically upregulated.","method":"BAC-based FRDA-EGFP fusion construct in stable cell lines, mitochondrial targeting verified by fluorescence, RT-PCR for expression, pharmacological treatment","journal":"The journal of gene medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct subcellular localization assay tied to functional genomic locus; pharmacological upregulation confirmed by multiple measures","pmids":["12516053"],"is_preprint":false},{"year":2013,"finding":"miR-124 (hsa-mir-124-3p) directly binds to the FXN 3'-UTR and downregulates frataxin expression; an FRDA-specific 3'-UTR haplotype confers reduced reporter gene expression compared to an alternative haplotype, establishing post-transcriptional regulation of FXN through miRNA targeting.","method":"Luciferase reporter assays with FXN 3'-UTR constructs, sequencing of 3'-UTR in FRDA cohorts, bioinformatic miRNA target prediction validated experimentally","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter functional validation plus cohort sequencing; single lab","pmids":["23382970"],"is_preprint":false},{"year":2020,"finding":"miRNA-224-5p directly targets FXN mRNA, resulting in decreases in both FXN mRNA and frataxin protein levels in FRDA cells; validated by luciferase assays and ZFN-mediated GAA repeat excision experiments.","method":"miRNAseq and RNAseq of FRDA vs. control cells, luciferase reporter assays, qRT-PCR, immunoblotting, ZFN-mediated GAA repeat excision","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (luciferase, qRT-PCR, immunoblot) confirming miR-224-5p targeting; single lab","pmids":["32291635"],"is_preprint":false},{"year":2013,"finding":"Increased 5-hydroxymethylcytosine (5hmC, not 5mC) is the predominant form of DNA methylation at the FXN upstream GAA region in FRDA cerebellum and heart tissues; decreased CTCF occupancy at the FXN 5' UTR was identified in FRDA cerebellum, implicating chromatin insulator disruption in FXN silencing.","method":"MethylScreen restriction enzyme digestion/qPCR distinguishing 5hmC vs 5mC, chromatin immunoprecipitation (ChIP) for CTCF","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specialized methylation assay distinguishing 5hmC/5mC plus ChIP; disease-relevant tissues; single lab","pmids":["24023969"],"is_preprint":false},{"year":2015,"finding":"FXN transcriptional deficiency in Friedreich ataxia results primarily from deficient transcriptional initiation (promoter silencing) across multiple cell types and tissues, as shown by metabolic labeling of newly synthesized transcripts in fibroblasts from the YG8sR humanized mouse model.","method":"Metabolic labeling of nascent transcripts, transgenic humanized mouse model comparison (YG8sR vs Y47R), multi-tissue qRT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct nascent transcript labeling measuring transcription initiation; in vivo model with multiple tissues; single lab","pmids":["26393353"],"is_preprint":false},{"year":2017,"finding":"TAT-MTScs-FXN fusion protein (frataxin delivered via TAT cell-penetrating peptide) reaches muscle mitochondria in vivo, restores succinate dehydrogenase activity, increases cell survival, decreases neurite degeneration, reduces apoptotic markers (α-fodrin cleavage, caspase 9 activation), rescues impaired HSP60 processing in frataxin-deficient DRG neurons, and prolongs lifespan in FRDA mouse models.","method":"TAT-peptide-frataxin protein delivery to DRG neurons and mice, mitochondrial fractionation, enzyme activity assay (succinate dehydrogenase), immunoblotting for apoptotic markers, lifespan analysis","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional readouts in both cell and animal models confirming mitochondrial delivery and functional rescue; single lab","pmids":["28980774"],"is_preprint":false},{"year":2017,"finding":"FXN81-210 (mature human frataxin) forms oligomers in the presence of iron under aerobic conditions; FXN81-210 and CyaY monomers pack in a head-to-tail, ring-shaped fashion with iron-binding sites at monomer interfaces; FXN81-210 oligomers are less stable than CyaY oligomers (dissociate after ~24 h) due to fewer acidic residues at the interface; FXN81-210 oligomerization is primarily driven by ferric iron while CyaY requires both ferric and ferrous iron.","method":"Dynamic light scattering, SAXS, electron microscopy, cross-linking mass spectrometry","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — multiple structural/biophysical techniques in a single study; mechanistic comparison of human and bacterial frataxin oligomerization","pmids":["29200434"],"is_preprint":false},{"year":2015,"finding":"Frataxin deficiency in hiPSC-derived cardiomyocytes leads to iron accumulation, ROS production, mitochondrial network disorganization, reduced respiratory chain proteins (CxII/COXIV), and impaired calcium handling; deferiprone (DFP) modulates iron homeostasis including the IRP-1/ferritin/transferrin receptor regulatory loop, restoring redox conditions and cardiac EC coupling function.","method":"hiPSC-derived FRDA cardiomyocytes, ROS assay, iron uptake measurement, immunoblotting for respiratory chain proteins, calcium imaging, drug treatment","journal":"International journal of cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic studies in disease-relevant human cell model with multiple readouts; single lab","pmids":["26625322"],"is_preprint":false},{"year":2016,"finding":"Compound heterozygous FRDA patients with mutations in the hydrophobic core of frataxin show reduced stability, while surface residue mutations affect frataxin interactions with iron-sulfur cluster assembly and heme biosynthetic proteins; null mutations (no frataxin) lead to significantly earlier disease onset and increased diabetes compared to those retaining partially functional frataxin.","method":"Structural modeling, stability analyses, systematic literature review of mutations, clinical regression analyses","journal":"Annals of neurology","confidence":"Low","confidence_rationale":"Tier 3–4 / Moderate — structural modeling and clinical correlation; no direct biochemical experiments on individual mutant proteins performed in this study","pmids":["26704351"],"is_preprint":false},{"year":2015,"finding":"miRNA-145 directly binds to the 3'-UTR of FXN and negatively regulates its expression; FXN deficiency downstream of miRNA-145 regulation affects apoptosis and mitochondrial function in cardiac cells.","method":"TargetScan bioinformatic prediction, real-time PCR of clinical samples, cell line experiments confirming direct 3'-UTR binding and negative regulation, apoptosis and mitochondrial function assays","journal":"Pediatric cardiology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — miRNA target validation by 3'-UTR binding confirmed experimentally, but full mechanistic chain is limited; single lab, no luciferase reporter mentioned explicitly","pmids":["26717909"],"is_preprint":false}],"current_model":"Frataxin (FXN) is an essential mitochondrial protein that functions as an iron chaperone and iron sensor regulating iron-sulfur (Fe-S) cluster biogenesis: it binds iron (Fe²⁺ and Fe³⁺) through a conserved anionic surface and interacts with the cysteine desulfurase IscS/NFS1 to modulate Fe-S cluster assembly on scaffold proteins (IscU/ISCU), with the bacterial ortholog CyaY acting as an iron-dependent inhibitor competing with IscX for the same IscS binding site; frataxin deficiency causes mitochondrial iron accumulation, reduced Fe-S cluster enzyme activities (aconitase, complex I/II subunits), increased reactive oxygen species, and impaired mitochondrial membrane potential, while at the transcriptional level, expanded GAA repeats in intron 1 induce heterochromatin-like epigenetic marks (including 5-hydroxymethylcytosine and reduced CTCF binding) that block both transcription initiation and elongation, with additional post-transcriptional downregulation mediated by miRNAs (including miR-124 and miR-224-5p) targeting the FXN 3'-UTR."},"narrative":{"mechanistic_narrative":"Frataxin (FXN) is an essential mitochondrial iron-binding protein that functions in iron-sulfur (Fe-S) cluster biogenesis and the protection of mitochondria from iron-mediated oxidative damage [PMID:11590127, PMID:19305405]. The protein adopts a conserved fold of a six-stranded antiparallel β-sheet flanked by two α-helices [PMID:10908679], presenting a highly anionic surface that binds both ferrous and ferric iron with weak, chaperone-like affinity and attenuates Fenton-driven hydroxyl radical production [PMID:15276847, PMID:15530368]. Through this iron-binding surface, frataxin acts as an iron-dependent regulator of Fe-S cluster assembly: the bacterial ortholog CyaY binds the cysteine desulfurase IscS to slow cluster formation on the IscU scaffold by modulating IscS enzymatic activity, with IscX competing for the same IscS surface to provide iron-concentration-dependent tuning of assembly rate [PMID:19305405, PMID:21799759, PMID:29457004]. Restoring frataxin to FRDA-deficient cells reverses mitochondrial iron accumulation, loss of membrane potential, and reduced Fe-S enzyme (aconitase) activity, while delivery of functional frataxin to deficient neurons and mice restores succinate dehydrogenase activity and reduces apoptotic signaling, directly establishing its role in mitochondrial iron homeostasis and oxidative protection [PMID:11590127, PMID:28980774]. In Friedreich ataxia, expanded GAA repeats in FXN intron 1 silence the gene through heterochromatin-like histone marks confined to the locus, blocking the transition from initiation to productive transcriptional elongation, with additional promoter-level initiation deficiency, altered 5-hydroxymethylcytosine and reduced CTCF occupancy, and post-transcriptional repression by miRNAs targeting the FXN 3′-UTR [PMID:21745819, PMID:26401053, PMID:24023969, PMID:23382970, PMID:32291635].","teleology":[{"year":1999,"claim":"Established whether the bacterial frataxin ortholog was essential, testing if its structural conservation implied a conserved indispensable iron role.","evidence":"Homologous recombination knockout of cyaY in E. coli with iron content and oxidant sensitivity readouts","pmids":["10452520"],"confidence":"Medium","gaps":["Negative result under normal conditions did not exclude a redundant or condition-specific role","No biochemical mechanism addressed"]},{"year":2000,"claim":"Defined the frataxin fold at atomic resolution, providing the structural framework for interpreting disease mutations and iron binding.","evidence":"X-ray crystallography of E. coli CyaY at 1.4 Å","pmids":["10908679"],"confidence":"High","gaps":["Structure alone did not assign function","Iron-binding surface not yet mapped"]},{"year":2001,"claim":"Placed frataxin causally in mitochondrial iron homeostasis by showing re-expression reverses the deficiency phenotype.","evidence":"Stable frataxin transfection of FRDA lymphoblasts with mitochondrial iron, membrane potential, and aconitase/ICDH assays","pmids":["11590127"],"confidence":"High","gaps":["Did not resolve direct molecular partners","Whether the defect is primary in Fe-S assembly vs iron sequestration unresolved"]},{"year":2004,"claim":"Characterized the iron-binding biochemistry and antioxidant behavior, supporting an iron chaperone role and mapping iron to a conserved anionic surface.","evidence":"ITC, EPR spin trapping, spectroscopy, ultracentrifugation, and NMR with mutagenesis of CyaY","pmids":["15276847","15530368"],"confidence":"High","gaps":["Weak affinity left physiological iron donation uncertain","Secondary CyaY sites absent in human frataxin limit direct extrapolation"]},{"year":2003,"claim":"Confirmed mitochondrial targeting from the native locus and demonstrated FXN expression is pharmacologically tunable.","evidence":"BAC FRDA-EGFP fusion in stable cells with fluorescence localization and pharmacological treatment","pmids":["12516053"],"confidence":"Medium","gaps":["Mechanism of hemin/butyrate upregulation not defined","Reporter context may differ from endogenous regulation"]},{"year":2009,"claim":"Resolved whether frataxin activates or inhibits Fe-S assembly by showing CyaY is an iron-dependent inhibitor binding IscS through its iron surface.","evidence":"Biochemical/biophysical binding to IscS, cluster formation kinetics, and iron-surface mutagenesis","pmids":["19305405"],"confidence":"High","gaps":["Inhibitory directionality differs from activating models reported for the human system","In vivo regulatory relevance not established here"]},{"year":2011,"claim":"Independently confirmed the inhibitory mechanism and localized the effect to IscS enzymatic activity, and separately established that GAA repeats block transcriptional elongation rather than initiation.","evidence":"Spectroscopic cluster-formation kinetics on IscU; ChIP-qPCR and GFP reporter with 560 GAA repeats plus pre-mRNA quantification","pmids":["21799759","21745819"],"confidence":"High","gaps":["Reconciliation of elongation-block vs initiation-block models for the disease locus unresolved","Cluster-type ratio unaffected leaves the precise regulatory output unclear"]},{"year":2015,"claim":"Defined the regulatory logic of frataxin in assembly via IscX competition and refined the chromatin and transcriptional basis of FXN silencing.","evidence":"Genetic cyaY/iscX epistasis; RNA-seq and ChIP confining heterochromatin to the FXN locus; nascent transcript labeling in a humanized mouse model","pmids":["25430730","26401053","26393353"],"confidence":"Medium","gaps":["Initiation-deficiency (YG8sR) vs elongation-block (patient cells) findings not fully reconciled","Whether bacterial IscX competition has a eukaryotic equivalent unknown"]},{"year":2013,"claim":"Identified post-transcriptional and epigenetic layers of FXN repression beyond the GAA chromatin defect.","evidence":"Luciferase 3′-UTR reporters with cohort sequencing (miR-124); MethylScreen and CTCF ChIP in FRDA cerebellum/heart","pmids":["23382970","24023969"],"confidence":"Medium","gaps":["Relative contribution of miRNA vs chromatin silencing to total deficit unquantified","Functional consequence of 5hmC/CTCF loss on transcription not directly tested"]},{"year":2017,"claim":"Demonstrated structural basis of iron-driven oligomerization and that exogenous functional frataxin can rescue mitochondrial enzyme and survival defects.","evidence":"DLS/SAXS/EM/cross-linking MS of human FXN81-210 and CyaY; TAT-MTScs-FXN delivery to DRG neurons and FRDA mice with enzyme and apoptosis readouts","pmids":["29200434","28980774"],"confidence":"Medium","gaps":["Physiological role of human frataxin oligomers uncertain given low stability","Delivery rescue durability and dosing not fully resolved"]},{"year":2020,"claim":"Extended the miRNA regulatory network controlling FXN levels.","evidence":"miRNAseq/RNAseq, luciferase, qRT-PCR, immunoblot, and ZFN GAA excision for miR-224-5p","pmids":["32291635"],"confidence":"Medium","gaps":["In vivo relevance to neuronal/cardiac tissue not established","Interaction with chromatin-level silencing unknown"]},{"year":null,"claim":"How the human frataxin–NFS1/ISCU regulatory interaction (inhibitory vs activating) and the relative weight of transcriptional, chromatin, and miRNA mechanisms combine to determine tissue-specific frataxin deficit remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Direct human FXN-NFS1-ISCU mechanism not biochemically resolved in this corpus","Quantitative apportioning of silencing mechanisms missing","Tissue-selectivity of pathology mechanistically unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,7]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[2,3,5]},{"term_id":"GO:0016209","term_label":"antioxidant activity","supporting_discovery_ids":[2,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[5,13,18]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,12,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,12,17]}],"complexes":[],"partners":["ISCS/NFS1","ISCU/ISCU","ISCX"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16595","full_name":"Frataxin, mitochondrial","aliases":["Friedreich ataxia protein","Fxn"],"length_aa":210,"mass_kda":23.1,"function":"Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly (PubMed:12785837, PubMed:24971490). Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release (PubMed:24971490). Binds ferrous ion and is released from FXN upon the addition of both L-cysteine and reduced FDX2 during [2Fe-2S] cluster assembly (PubMed:29576242). The core iron-sulfur cluster (ISC) assembly complex is involved in the de novo synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial iron-sulfur protein biogenesis. This process is initiated by the cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1) that produces persulfide which is delivered on the scaffold protein ISCU in a FXN-dependent manner. Then this complex is stabilized by FDX2 which provides reducing equivalents to accomplish the [2Fe-2S] cluster assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to chaperone proteins, including HSCB, HSPA9 and GLRX5 (By similarity). May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity (PubMed:15641778). May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems (PubMed:11823441, PubMed:12755598). May function as an iron chaperone protein that protects the aconitase [4Fe-4S]2+ cluster from disassembly and promotes enzyme reactivation (PubMed:15247478). May play a role as a high affinity iron binding partner for FECH that is capable of both delivering iron to ferrochelatase and mediating the terminal step in mitochondrial heme biosynthesis (PubMed:15123683, PubMed:16239244) Modulates the RNA-binding activity of ACO1 (PubMed:20053667). May be involved in the cytoplasmic iron-sulfur protein biogenesis (PubMed:16091420). May contribute to oxidative stress resistance and overall cell survival (PubMed:16608849)","subcellular_location":"Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q16595/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/FXN","classification":"Common Essential","n_dependent_lines":835,"n_total_lines":1208,"dependency_fraction":0.6912251655629139},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FXN","total_profiled":1310},"omim":[{"mim_id":"616541","title":"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED","url":"https://www.omim.org/entry/616541"},{"mim_id":"614575","title":"CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS","url":"https://www.omim.org/entry/614575"},{"mim_id":"613311","title":"LYR MOTIF-CONTAINING PROTEIN 4; LYRM4","url":"https://www.omim.org/entry/613311"},{"mim_id":"613036","title":"PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA; PMPCA","url":"https://www.omim.org/entry/613036"},{"mim_id":"611911","title":"IRON-SULFUR CLUSTER ASSEMBLY ENZYME; ISCU","url":"https://www.omim.org/entry/611911"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FXN"},"hgnc":{"alias_symbol":["FA","FARR","X25","CyaY"],"prev_symbol":["FRDA"]},"alphafold":{"accession":"Q16595","domains":[{"cath_id":"3.30.920.10","chopping":"86-193","consensus_level":"high","plddt":93.7219,"start":86,"end":193}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16595","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16595-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16595-F1-predicted_aligned_error_v6.png","plddt_mean":75.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FXN","jax_strain_url":"https://www.jax.org/strain/search?query=FXN"},"sequence":{"accession":"Q16595","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16595.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16595/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16595"}},"corpus_meta":[{"pmid":"12644592","id":"PMC_12644592","title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12644592","citation_count":472,"is_preprint":false},{"pmid":"17526015","id":"PMC_17526015","title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.","date":"2007","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17526015","citation_count":247,"is_preprint":false},{"pmid":"19305405","id":"PMC_19305405","title":"Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS.","date":"2009","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19305405","citation_count":207,"is_preprint":false},{"pmid":"30481673","id":"PMC_30481673","title":"The roles of free ammonia (FA) in biological wastewater treatment processes: A review.","date":"2018","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/30481673","citation_count":196,"is_preprint":false},{"pmid":"2200706","id":"PMC_2200706","title":"Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats.","date":"1990","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2200706","citation_count":149,"is_preprint":false},{"pmid":"12697710","id":"PMC_12697710","title":"Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats.","date":"2003","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12697710","citation_count":138,"is_preprint":false},{"pmid":"9618284","id":"PMC_9618284","title":"Leptin receptor signal transduction: OBRa and OBRb of fa type.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9618284","citation_count":127,"is_preprint":false},{"pmid":"26704351","id":"PMC_26704351","title":"Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.","date":"2016","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26704351","citation_count":119,"is_preprint":false},{"pmid":"15995177","id":"PMC_15995177","title":"Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats.","date":"2005","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15995177","citation_count":119,"is_preprint":false},{"pmid":"15530368","id":"PMC_15530368","title":"Solution structure of the bacterial frataxin ortholog, CyaY: mapping the iron binding sites.","date":"2004","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/15530368","citation_count":114,"is_preprint":false},{"pmid":"11225714","id":"PMC_11225714","title":"Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats.","date":"2000","source":"Obesity research","url":"https://pubmed.ncbi.nlm.nih.gov/11225714","citation_count":107,"is_preprint":false},{"pmid":"15276847","id":"PMC_15276847","title":"Iron binding and oxidation kinetics in frataxin CyaY of Escherichia coli.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15276847","citation_count":103,"is_preprint":false},{"pmid":"10049703","id":"PMC_10049703","title":"Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10049703","citation_count":99,"is_preprint":false},{"pmid":"10908679","id":"PMC_10908679","title":"Crystal structure of Escherichia coli CyaY protein reveals a previously unidentified fold for the evolutionarily conserved frataxin family.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10908679","citation_count":97,"is_preprint":false},{"pmid":"19371427","id":"PMC_19371427","title":"CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors.","date":"2009","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19371427","citation_count":96,"is_preprint":false},{"pmid":"22522441","id":"PMC_22522441","title":"FXN methylation predicts expression and clinical outcome in Friedreich ataxia.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22522441","citation_count":93,"is_preprint":false},{"pmid":"11590127","id":"PMC_11590127","title":"Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11590127","citation_count":74,"is_preprint":false},{"pmid":"22343915","id":"PMC_22343915","title":"FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22343915","citation_count":73,"is_preprint":false},{"pmid":"17221219","id":"PMC_17221219","title":"The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.","date":"2007","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/17221219","citation_count":72,"is_preprint":false},{"pmid":"22396592","id":"PMC_22396592","title":"Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22396592","citation_count":70,"is_preprint":false},{"pmid":"16092047","id":"PMC_16092047","title":"Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.","date":"2005","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/16092047","citation_count":69,"is_preprint":false},{"pmid":"21745819","id":"PMC_21745819","title":"Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21745819","citation_count":65,"is_preprint":false},{"pmid":"9811933","id":"PMC_9811933","title":"Parental gender, age at birth and expansion length influence GAA repeat intergenerational instability in the X25 gene: pedigree studies and analysis of sperm from patients with Friedreich's ataxia.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9811933","citation_count":64,"is_preprint":false},{"pmid":"26401053","id":"PMC_26401053","title":"Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26401053","citation_count":64,"is_preprint":false},{"pmid":"10452520","id":"PMC_10452520","title":"Knock-out of the cyaY gene in Escherichia coli does not affect cellular iron content and sensitivity to oxidants.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10452520","citation_count":61,"is_preprint":false},{"pmid":"14645274","id":"PMC_14645274","title":"FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism.","date":"2003","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/14645274","citation_count":60,"is_preprint":false},{"pmid":"12968669","id":"PMC_12968669","title":"Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats.","date":"2003","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/12968669","citation_count":59,"is_preprint":false},{"pmid":"12516053","id":"PMC_12516053","title":"Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.","date":"2003","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12516053","citation_count":57,"is_preprint":false},{"pmid":"6446651","id":"PMC_6446651","title":"Genetic and physical characterization of lambda transducing phages (lambda frdA) containing the fumarate reductase gene of Escherichia coli K12.","date":"1980","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/6446651","citation_count":49,"is_preprint":false},{"pmid":"2244791","id":"PMC_2244791","title":"The fumarate reductase operon of Wolinella succinogenes. Sequence and expression of the frdA and frdB genes.","date":"1990","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/2244791","citation_count":47,"is_preprint":false},{"pmid":"16924691","id":"PMC_16924691","title":"Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.","date":"2006","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/16924691","citation_count":47,"is_preprint":false},{"pmid":"22027239","id":"PMC_22027239","title":"Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution.","date":"2011","source":"Nanoscale research letters","url":"https://pubmed.ncbi.nlm.nih.gov/22027239","citation_count":47,"is_preprint":false},{"pmid":"30176311","id":"PMC_30176311","title":"Causes and solutions to \"globesity\": The new fa(s)t alarming global epidemic.","date":"2018","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/30176311","citation_count":46,"is_preprint":false},{"pmid":"22095831","id":"PMC_22095831","title":"DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22095831","citation_count":44,"is_preprint":false},{"pmid":"17235301","id":"PMC_17235301","title":"Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich's ataxia deficiency in human cells.","date":"2007","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/17235301","citation_count":43,"is_preprint":false},{"pmid":"22409940","id":"PMC_22409940","title":"Exonic deletions of FXN and early-onset Friedreich ataxia.","date":"2012","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22409940","citation_count":39,"is_preprint":false},{"pmid":"8404676","id":"PMC_8404676","title":"Decreased expression of protein kinase-C alpha, beta, and epsilon in soleus muscle of Zucker obese (fa/fa) rats.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8404676","citation_count":39,"is_preprint":false},{"pmid":"32192487","id":"PMC_32192487","title":"FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32192487","citation_count":38,"is_preprint":false},{"pmid":"21799759","id":"PMC_21799759","title":"The role of CyaY in iron sulfur cluster assembly on the E. coli IscU scaffold protein.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21799759","citation_count":38,"is_preprint":false},{"pmid":"7805834","id":"PMC_7805834","title":"Identification of a fatty acyl responsive regulator (FarR) in Escherichia coli.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7805834","citation_count":38,"is_preprint":false},{"pmid":"9061714","id":"PMC_9061714","title":"Differential responsiveness of obese (fa/fa) and lean (Fa/Fa) Zucker rats to cytokine-induced anorexia.","date":"1997","source":"Obesity research","url":"https://pubmed.ncbi.nlm.nih.gov/9061714","citation_count":38,"is_preprint":false},{"pmid":"14645248","id":"PMC_14645248","title":"Phosphotransferase-mediated transport of the osmolyte 2-O-alpha-mannosyl-D-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) gene and is regulated by the mngR (farR) gene product acting as repressor.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14645248","citation_count":38,"is_preprint":false},{"pmid":"16357529","id":"PMC_16357529","title":"Assessing the link between BACH1 and BRCA1 in the FA pathway.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16357529","citation_count":36,"is_preprint":false},{"pmid":"33328587","id":"PMC_33328587","title":"Degradation of FA reduces Aβ neurotoxicity and Alzheimer-related phenotypes.","date":"2020","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33328587","citation_count":36,"is_preprint":false},{"pmid":"9588463","id":"PMC_9588463","title":"An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene.","date":"1998","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9588463","citation_count":36,"is_preprint":false},{"pmid":"23418481","id":"PMC_23418481","title":"Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23418481","citation_count":36,"is_preprint":false},{"pmid":"25430730","id":"PMC_25430730","title":"The iron-binding CyaY and IscX proteins assist the ISC-catalyzed Fe-S biogenesis in Escherichia coli.","date":"2015","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25430730","citation_count":35,"is_preprint":false},{"pmid":"32397542","id":"PMC_32397542","title":"Obesity and Age-Related Changes in the Brain of the Zucker Lepr  Rats.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32397542","citation_count":34,"is_preprint":false},{"pmid":"10586122","id":"PMC_10586122","title":"Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line.","date":"1999","source":"European cytokine network","url":"https://pubmed.ncbi.nlm.nih.gov/10586122","citation_count":34,"is_preprint":false},{"pmid":"24421039","id":"PMC_24421039","title":"Distinct roles of the Salmonella enterica serovar Typhimurium CyaY and YggX proteins in the biosynthesis and repair of iron-sulfur clusters.","date":"2014","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24421039","citation_count":33,"is_preprint":false},{"pmid":"29608678","id":"PMC_29608678","title":"FA-SAT Is an Old Satellite DNA Frozen in Several Bilateria Genomes.","date":"2017","source":"Genome biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/29608678","citation_count":32,"is_preprint":false},{"pmid":"18000367","id":"PMC_18000367","title":"Disruption of the FA/BRCA pathway in bladder cancer.","date":"2007","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/18000367","citation_count":32,"is_preprint":false},{"pmid":"26625322","id":"PMC_26625322","title":"Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.","date":"2015","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26625322","citation_count":31,"is_preprint":false},{"pmid":"28980774","id":"PMC_28980774","title":"Frataxin-deficient neurons and mice models of Friedreich ataxia are improved by TAT-MTScs-FXN treatment.","date":"2017","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28980774","citation_count":31,"is_preprint":false},{"pmid":"26849417","id":"PMC_26849417","title":"Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency.","date":"2016","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26849417","citation_count":31,"is_preprint":false},{"pmid":"28558075","id":"PMC_28558075","title":"A never-ending story: the steadily growing family of the FA and FA-like genes.","date":"2017","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28558075","citation_count":30,"is_preprint":false},{"pmid":"28182935","id":"PMC_28182935","title":"Infectious Delivery and Expression of a 135 kb Human FRDA Genomic DNA Locus Complements Friedreich's Ataxia Deficiency in Human Cells.","date":"2016","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28182935","citation_count":29,"is_preprint":false},{"pmid":"32102800","id":"PMC_32102800","title":"SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect FA translocation.","date":"2020","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/32102800","citation_count":29,"is_preprint":false},{"pmid":"31904895","id":"PMC_31904895","title":"Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: The IMAGE-FRDA study.","date":"2020","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/31904895","citation_count":28,"is_preprint":false},{"pmid":"7374443","id":"PMC_7374443","title":"Adipocyte size distribution in fa/fa rats during development.","date":"1980","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/7374443","citation_count":27,"is_preprint":false},{"pmid":"22267503","id":"PMC_22267503","title":"A Boolean network model of the FA/BRCA pathway.","date":"2012","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22267503","citation_count":27,"is_preprint":false},{"pmid":"10329976","id":"PMC_10329976","title":"Leptin responsiveness and gene dosage for leptin receptor mutation (fa) in newborn rats.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10329976","citation_count":27,"is_preprint":false},{"pmid":"17650323","id":"PMC_17650323","title":"Effects of the deletion of the Escherichia coli frataxin homologue CyaY on the respiratory NADH:ubiquinone oxidoreductase.","date":"2007","source":"BMC biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17650323","citation_count":26,"is_preprint":false},{"pmid":"23382970","id":"PMC_23382970","title":"Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23382970","citation_count":26,"is_preprint":false},{"pmid":"19379763","id":"PMC_19379763","title":"FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA.","date":"2009","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/19379763","citation_count":25,"is_preprint":false},{"pmid":"26717909","id":"PMC_26717909","title":"MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN.","date":"2015","source":"Pediatric cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26717909","citation_count":25,"is_preprint":false},{"pmid":"29457004","id":"PMC_29457004","title":"The Molecular Bases of the Dual Regulation of Bacterial Iron Sulfur Cluster Biogenesis by CyaY and IscX.","date":"2018","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/29457004","citation_count":25,"is_preprint":false},{"pmid":"10668723","id":"PMC_10668723","title":"Atypical Friedreich ataxia phenotype associated with a novel missense mutation in the X25 gene.","date":"2000","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10668723","citation_count":25,"is_preprint":false},{"pmid":"6114892","id":"PMC_6114892","title":"Serum insulin and lipogenesis in the suckling 'fatty' fa/fa rat.","date":"1981","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/6114892","citation_count":25,"is_preprint":false},{"pmid":"27550963","id":"PMC_27550963","title":"Defects in homologous recombination repair behind the human diseases: FA and HBOC.","date":"2016","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27550963","citation_count":24,"is_preprint":false},{"pmid":"25096861","id":"PMC_25096861","title":"Epigenetics and development of food allergy (FA) in early childhood.","date":"2014","source":"Current allergy and asthma reports","url":"https://pubmed.ncbi.nlm.nih.gov/25096861","citation_count":23,"is_preprint":false},{"pmid":"17727661","id":"PMC_17727661","title":"Partial conservation of functions between eukaryotic frataxin and the Escherichia coli frataxin homolog CyaY.","date":"2007","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/17727661","citation_count":23,"is_preprint":false},{"pmid":"23196337","id":"PMC_23196337","title":"Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene.","date":"2012","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23196337","citation_count":23,"is_preprint":false},{"pmid":"21458504","id":"PMC_21458504","title":"Characterization of E. coli MG1655 and frdA and sdhC mutants at various aerobiosis levels.","date":"2011","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21458504","citation_count":22,"is_preprint":false},{"pmid":"24023969","id":"PMC_24023969","title":"Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023969","citation_count":22,"is_preprint":false},{"pmid":"18483478","id":"PMC_18483478","title":"Abnormal immune responses in fa/fa Zucker rats and effects of feeding conjugated linoleic acid.","date":"2008","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18483478","citation_count":22,"is_preprint":false},{"pmid":"24451376","id":"PMC_24451376","title":"The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24451376","citation_count":22,"is_preprint":false},{"pmid":"25953249","id":"PMC_25953249","title":"A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.","date":"2015","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/25953249","citation_count":21,"is_preprint":false},{"pmid":"18473727","id":"PMC_18473727","title":"BRCA-FA pathway as a target for anti-tumor drugs.","date":"2008","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18473727","citation_count":20,"is_preprint":false},{"pmid":"20576113","id":"PMC_20576113","title":"Remarkable features of ovarian morphology and reproductive hormones in insulin-resistant Zucker fatty (fa/fa) rats.","date":"2010","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/20576113","citation_count":20,"is_preprint":false},{"pmid":"10969848","id":"PMC_10969848","title":"Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10969848","citation_count":19,"is_preprint":false},{"pmid":"10600923","id":"PMC_10600923","title":"Corticotropin-releasing hormone-binding protein in brain and pituitary of food-deprived obese (fa/fa) Zucker rats.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10600923","citation_count":19,"is_preprint":false},{"pmid":"20519958","id":"PMC_20519958","title":"A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20519958","citation_count":19,"is_preprint":false},{"pmid":"28552166","id":"PMC_28552166","title":"Activation of the FA pathway mediated by phosphorylation and ubiquitination.","date":"2017","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/28552166","citation_count":18,"is_preprint":false},{"pmid":"31673878","id":"PMC_31673878","title":"The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype.","date":"2019","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31673878","citation_count":18,"is_preprint":false},{"pmid":"26393353","id":"PMC_26393353","title":"FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26393353","citation_count":18,"is_preprint":false},{"pmid":"11852181","id":"PMC_11852181","title":"Identification of a novel transcript of X25, the human gene involved in Friedreich ataxia.","date":"2002","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/11852181","citation_count":18,"is_preprint":false},{"pmid":"24175286","id":"PMC_24175286","title":"Frataxin mRNA isoforms in FRDA patients and normal subjects: effect of tocotrienol supplementation.","date":"2013","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24175286","citation_count":17,"is_preprint":false},{"pmid":"29797089","id":"PMC_29797089","title":"The Mechanism FA-Dependent H+ Transport by UCP1.","date":"2019","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29797089","citation_count":17,"is_preprint":false},{"pmid":"11417948","id":"PMC_11417948","title":"Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 rats.","date":"2001","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/11417948","citation_count":17,"is_preprint":false},{"pmid":"26635519","id":"PMC_26635519","title":"Analyzing the Effects of a G137V Mutation in the FXN Gene.","date":"2015","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26635519","citation_count":16,"is_preprint":false},{"pmid":"30082297","id":"PMC_30082297","title":"Oligomerization of the FERM-FA protein Yurt controls epithelial cell polarity.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30082297","citation_count":16,"is_preprint":false},{"pmid":"11843702","id":"PMC_11843702","title":"Intrafamilial phenotypic variability in Friedreich ataxia associated with a G130V mutation in the FRDA gene.","date":"2002","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11843702","citation_count":16,"is_preprint":false},{"pmid":"32291635","id":"PMC_32291635","title":"A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.","date":"2020","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32291635","citation_count":16,"is_preprint":false},{"pmid":"29200434","id":"PMC_29200434","title":"Iron-induced oligomerization of human FXN81-210 and bacterial CyaY frataxin and the effect of iron chelators.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29200434","citation_count":14,"is_preprint":false},{"pmid":"25133712","id":"PMC_25133712","title":"Phylogenetic analyses and characterization of RNase X25 from Drosophila melanogaster suggest a conserved housekeeping role and additional functions for RNase T2 enzymes in protostomes.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25133712","citation_count":14,"is_preprint":false},{"pmid":"1647765","id":"PMC_1647765","title":"Stimulation of FA and casein kinase II by insulin in 3T3-L1 cells.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1647765","citation_count":14,"is_preprint":false},{"pmid":"16796676","id":"PMC_16796676","title":"Integration Host Factor is required for FarR repression of the farAB-encoded efflux pump of Neisseria gonorrhoeae.","date":"2006","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16796676","citation_count":14,"is_preprint":false},{"pmid":"15965784","id":"PMC_15965784","title":"Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.","date":"2005","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/15965784","citation_count":14,"is_preprint":false},{"pmid":"9548215","id":"PMC_9548215","title":"Ultrastructural and secretory heterogeneity of fa/fa (Zucker) rat islets.","date":"1998","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9548215","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48653,"output_tokens":5701,"usd":0.115737,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14556,"output_tokens":3653,"usd":0.082053,"stage2_stop_reason":"end_turn"},"total_usd":0.19779,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Bacterial frataxin ortholog CyaY acts as an iron-dependent inhibitor of iron-sulfur (Fe-S) cluster formation by binding to the desulfurase IscS through its iron-binding surface, functioning as an iron sensor/regulator that fine-tunes Fe-S cluster assembly relative to available acceptor concentration.\",\n      \"method\": \"Biochemical and biophysical assays (iron-dependent binding to IscS, kinetic measurements of cluster formation, site-directed analysis of iron-binding surface)\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical and biophysical methods in a focused mechanistic study; binding to IscS directly demonstrated and inhibitory mechanism characterized\",\n      \"pmids\": [\"19305405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The crystal structure of E. coli frataxin ortholog CyaY was solved at 1.4 Å resolution, revealing a novel fold consisting of a six-stranded antiparallel β-sheet flanked by two α-helices, predicted to be shared by all frataxin family members and providing a framework for interpreting disease-associated mutations.\",\n      \"method\": \"X-ray crystallography (1.4 Å resolution)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure determination with clear functional interpretation; foundational structural result\",\n      \"pmids\": [\"10908679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CyaY (bacterial frataxin ortholog) binds at least two ferrous ions per monomer with weak affinity (Kd ~4 µM), consistent with an iron chaperone role; Fe(II) is oxidized rapidly by H2O2 (not O2) with stoichiometry of 2 Fe(II)/H2O2, greatly attenuating hydroxyl radical production from Fenton chemistry; up to ~25–26 Fe(III) ions can bind per monomer, and iron addition induces tetramerization.\",\n      \"method\": \"Isothermal titration calorimetry (ITC), EPR spin trapping, UV-visible/fluorescence spectroscopy, iron analysis, pH-stat titrations, analytical ultracentrifugation\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro methods in a single rigorous study measuring binding stoichiometry, oxidation kinetics, and oligomerization\",\n      \"pmids\": [\"15276847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The solution structure of CyaY was solved by NMR; iron binding was mapped to a highly anionic surface of the molecule (conserved across frataxin family) that hosts both Fe(2+) and Fe(3+) with defined stoichiometry without requiring aggregation; secondary binding sites on CyaY (absent in human frataxin) may underlie its polymerization mechanism.\",\n      \"method\": \"NMR structure determination, mutagenesis of iron-binding surface, comparative binding studies with wild-type vs. mutant CyaY\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure plus mutagenesis functional validation; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"15530368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CyaY slows down Fe-S cluster formation on the IscU scaffold protein and does not alter the relative ratio of [2Fe2S]²⁺ to [4Fe4S]²⁺ clusters but directly affects the enzymatic activity of IscS, independently confirming an inhibitory rather than activating role for the bacterial frataxin ortholog.\",\n      \"method\": \"Spectroscopic characterization of cluster formation kinetics (UV-vis, resonance Raman, EPR, Mössbauer), enzymatic assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple spectroscopic methods independently confirming CyaY inhibitory mechanism on IscS/IscU system\",\n      \"pmids\": [\"21799759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Frataxin expression in Friedreich's ataxia lymphoblasts rescues mitochondrial iron homeostasis and membrane potential defects: FXN-deficient cells showed increased filtrable mitochondrial iron, decreased mitochondrial membrane potential (MMP), and reduced aconitase/ICDH activities, all of which were reversed by transfection of frataxin to near-physiological levels, establishing frataxin's direct role in mitochondrial iron homeostasis and protection from oxidative stress.\",\n      \"method\": \"Stable transfection of frataxin into FRDA compound heterozygote lymphoblasts, mitochondrial iron measurement, MMP measurement, aconitase/ICDH enzyme assays, oxidative stress challenge\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean rescue/complementation experiment with multiple orthogonal functional readouts; direct mechanistic placement of frataxin in mitochondrial iron homeostasis\",\n      \"pmids\": [\"11590127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CyaY is a member of the ISC pathway for Fe-S cluster protein maturation in E. coli, requiring iron-rich conditions for its contribution; a genetic interaction was discovered between cyaY and iscX (additive effect on Fe-S cluster maturation when both genes are deleted), establishing IscX as a co-regulator.\",\n      \"method\": \"Genetic knockout/double knockout, in vivo Fe-S cluster protein activity assays, growth phenotype analysis under iron-variable conditions\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"25430730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IscX (YfhJ) competes with CyaY for the same binding surface on IscS; at low iron concentrations IscX rescues the CyaY-inhibited rate of enzymatic Fe-S cluster formation, while at high iron the competition effect is negligible, establishing a dual iron-concentration-dependent regulatory mechanism of Fe-S cluster assembly mediated by the CyaY/IscX competition.\",\n      \"method\": \"NMR, small-angle X-ray scattering (SAXS), biochemical competition assays, kinetic measurements of cluster assembly\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural (NMR/SAXS) plus biochemical competition assays demonstrating mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29457004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Knockout of cyaY in E. coli did not affect cellular iron content or sensitivity to oxidants under normal conditions, suggesting that despite structural similarities CyaY may have a different or redundant function compared to mitochondrial frataxin homologs in eukaryotes.\",\n      \"method\": \"Homologous recombination knockout, iron content measurement, H2O2 sensitivity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean loss-of-function experiment with defined readouts, single lab; negative result mechanistically informative (functional redundancy in bacteria)\",\n      \"pmids\": [\"10452520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CyaY (frataxin ortholog) expressed as a mitochondria-targeted form in S. cerevisiae yfh1Δ complemented loss of Fe-S cluster enzyme activities and heme synthesis, maintaining near-normal respiratory growth and protecting against oxidative damage, demonstrating partial conservation of frataxin function between prokaryotes and eukaryotes.\",\n      \"method\": \"Mitochondria-targeted expression of CyaY in frataxin-null yeast, respiratory growth assays, Fe-S enzyme activity measurements, oxidative stress assays\",\n      \"journal\": \"FEMS yeast research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic complementation with multiple functional assays; demonstrates functional conservation and iron/Fe-S role\",\n      \"pmids\": [\"17727661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Deletion of cyaY in E. coli reduces the amount of assembled respiratory complex I (NADH:ubiquinone oxidoreductase) by one third, but the assembled complex retains full activity and all iron-sulfur clusters; live-cell GFP imaging and fractionation showed CyaY localizes to the cytoplasm, not the membrane, establishing a non-essential assembly role rather than structural component role.\",\n      \"method\": \"cyaY deletion mutant analysis, Western blot, live-cell GFP imaging, subcellular fractionation, complex I activity assay\",\n      \"journal\": \"BMC biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment combined with loss-of-function and biochemical characterization, single lab\",\n      \"pmids\": [\"17650323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Expanded GAA repeats in FXN intron 1 induce heterochromatin-like histone modifications downstream of the promoter (near the GAA tract) and impede the transition from transcription initiation to productive elongation; pre-mRNA levels upstream of the GAA repeats were similar in FRDA and control cells, establishing that the primary block is at post-initiation/elongation, not initiation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) with quantitative PCR, GFP reporter assay with 560 GAA repeats, pre-mRNA quantification by qPCR\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — orthogonal ChIP and reporter assays with quantitative controls; independently consistent results across patient cells and reporter model\",\n      \"pmids\": [\"21745819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Expanded GAA repeats impede transcription elongation through the FXN locus without affecting neighboring genes; deep sequencing of FXN pre-mRNA revealed a pronounced elongation defect in FRDA cells; ChIP studies confirmed heterochromatin histone marks are confined to the FXN locus and not spread to flanking genomic regions.\",\n      \"method\": \"Next-generation RNA sequencing of FRDA and control fibroblasts, FXN pre-mRNA deep sequencing, ChIP with histone modification antibodies\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — large cohort RNA-seq with orthogonal ChIP studies confirming locus-restricted silencing and elongation defect\",\n      \"pmids\": [\"26401053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Frataxin-EGFP fusion proteins are targeted to mitochondria when driven by the endogenous FRDA locus regulatory elements; hemin and butyric acid enhance FRDA gene expression from the intact locus, establishing that FXN expression can be pharmacologically upregulated.\",\n      \"method\": \"BAC-based FRDA-EGFP fusion construct in stable cell lines, mitochondrial targeting verified by fluorescence, RT-PCR for expression, pharmacological treatment\",\n      \"journal\": \"The journal of gene medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct subcellular localization assay tied to functional genomic locus; pharmacological upregulation confirmed by multiple measures\",\n      \"pmids\": [\"12516053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"miR-124 (hsa-mir-124-3p) directly binds to the FXN 3'-UTR and downregulates frataxin expression; an FRDA-specific 3'-UTR haplotype confers reduced reporter gene expression compared to an alternative haplotype, establishing post-transcriptional regulation of FXN through miRNA targeting.\",\n      \"method\": \"Luciferase reporter assays with FXN 3'-UTR constructs, sequencing of 3'-UTR in FRDA cohorts, bioinformatic miRNA target prediction validated experimentally\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter functional validation plus cohort sequencing; single lab\",\n      \"pmids\": [\"23382970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miRNA-224-5p directly targets FXN mRNA, resulting in decreases in both FXN mRNA and frataxin protein levels in FRDA cells; validated by luciferase assays and ZFN-mediated GAA repeat excision experiments.\",\n      \"method\": \"miRNAseq and RNAseq of FRDA vs. control cells, luciferase reporter assays, qRT-PCR, immunoblotting, ZFN-mediated GAA repeat excision\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (luciferase, qRT-PCR, immunoblot) confirming miR-224-5p targeting; single lab\",\n      \"pmids\": [\"32291635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Increased 5-hydroxymethylcytosine (5hmC, not 5mC) is the predominant form of DNA methylation at the FXN upstream GAA region in FRDA cerebellum and heart tissues; decreased CTCF occupancy at the FXN 5' UTR was identified in FRDA cerebellum, implicating chromatin insulator disruption in FXN silencing.\",\n      \"method\": \"MethylScreen restriction enzyme digestion/qPCR distinguishing 5hmC vs 5mC, chromatin immunoprecipitation (ChIP) for CTCF\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specialized methylation assay distinguishing 5hmC/5mC plus ChIP; disease-relevant tissues; single lab\",\n      \"pmids\": [\"24023969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FXN transcriptional deficiency in Friedreich ataxia results primarily from deficient transcriptional initiation (promoter silencing) across multiple cell types and tissues, as shown by metabolic labeling of newly synthesized transcripts in fibroblasts from the YG8sR humanized mouse model.\",\n      \"method\": \"Metabolic labeling of nascent transcripts, transgenic humanized mouse model comparison (YG8sR vs Y47R), multi-tissue qRT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct nascent transcript labeling measuring transcription initiation; in vivo model with multiple tissues; single lab\",\n      \"pmids\": [\"26393353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TAT-MTScs-FXN fusion protein (frataxin delivered via TAT cell-penetrating peptide) reaches muscle mitochondria in vivo, restores succinate dehydrogenase activity, increases cell survival, decreases neurite degeneration, reduces apoptotic markers (α-fodrin cleavage, caspase 9 activation), rescues impaired HSP60 processing in frataxin-deficient DRG neurons, and prolongs lifespan in FRDA mouse models.\",\n      \"method\": \"TAT-peptide-frataxin protein delivery to DRG neurons and mice, mitochondrial fractionation, enzyme activity assay (succinate dehydrogenase), immunoblotting for apoptotic markers, lifespan analysis\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional readouts in both cell and animal models confirming mitochondrial delivery and functional rescue; single lab\",\n      \"pmids\": [\"28980774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FXN81-210 (mature human frataxin) forms oligomers in the presence of iron under aerobic conditions; FXN81-210 and CyaY monomers pack in a head-to-tail, ring-shaped fashion with iron-binding sites at monomer interfaces; FXN81-210 oligomers are less stable than CyaY oligomers (dissociate after ~24 h) due to fewer acidic residues at the interface; FXN81-210 oligomerization is primarily driven by ferric iron while CyaY requires both ferric and ferrous iron.\",\n      \"method\": \"Dynamic light scattering, SAXS, electron microscopy, cross-linking mass spectrometry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple structural/biophysical techniques in a single study; mechanistic comparison of human and bacterial frataxin oligomerization\",\n      \"pmids\": [\"29200434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Frataxin deficiency in hiPSC-derived cardiomyocytes leads to iron accumulation, ROS production, mitochondrial network disorganization, reduced respiratory chain proteins (CxII/COXIV), and impaired calcium handling; deferiprone (DFP) modulates iron homeostasis including the IRP-1/ferritin/transferrin receptor regulatory loop, restoring redox conditions and cardiac EC coupling function.\",\n      \"method\": \"hiPSC-derived FRDA cardiomyocytes, ROS assay, iron uptake measurement, immunoblotting for respiratory chain proteins, calcium imaging, drug treatment\",\n      \"journal\": \"International journal of cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic studies in disease-relevant human cell model with multiple readouts; single lab\",\n      \"pmids\": [\"26625322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Compound heterozygous FRDA patients with mutations in the hydrophobic core of frataxin show reduced stability, while surface residue mutations affect frataxin interactions with iron-sulfur cluster assembly and heme biosynthetic proteins; null mutations (no frataxin) lead to significantly earlier disease onset and increased diabetes compared to those retaining partially functional frataxin.\",\n      \"method\": \"Structural modeling, stability analyses, systematic literature review of mutations, clinical regression analyses\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 / Moderate — structural modeling and clinical correlation; no direct biochemical experiments on individual mutant proteins performed in this study\",\n      \"pmids\": [\"26704351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miRNA-145 directly binds to the 3'-UTR of FXN and negatively regulates its expression; FXN deficiency downstream of miRNA-145 regulation affects apoptosis and mitochondrial function in cardiac cells.\",\n      \"method\": \"TargetScan bioinformatic prediction, real-time PCR of clinical samples, cell line experiments confirming direct 3'-UTR binding and negative regulation, apoptosis and mitochondrial function assays\",\n      \"journal\": \"Pediatric cardiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — miRNA target validation by 3'-UTR binding confirmed experimentally, but full mechanistic chain is limited; single lab, no luciferase reporter mentioned explicitly\",\n      \"pmids\": [\"26717909\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Frataxin (FXN) is an essential mitochondrial protein that functions as an iron chaperone and iron sensor regulating iron-sulfur (Fe-S) cluster biogenesis: it binds iron (Fe²⁺ and Fe³⁺) through a conserved anionic surface and interacts with the cysteine desulfurase IscS/NFS1 to modulate Fe-S cluster assembly on scaffold proteins (IscU/ISCU), with the bacterial ortholog CyaY acting as an iron-dependent inhibitor competing with IscX for the same IscS binding site; frataxin deficiency causes mitochondrial iron accumulation, reduced Fe-S cluster enzyme activities (aconitase, complex I/II subunits), increased reactive oxygen species, and impaired mitochondrial membrane potential, while at the transcriptional level, expanded GAA repeats in intron 1 induce heterochromatin-like epigenetic marks (including 5-hydroxymethylcytosine and reduced CTCF binding) that block both transcription initiation and elongation, with additional post-transcriptional downregulation mediated by miRNAs (including miR-124 and miR-224-5p) targeting the FXN 3'-UTR.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Frataxin (FXN) is an essential mitochondrial iron-binding protein that functions in iron-sulfur (Fe-S) cluster biogenesis and the protection of mitochondria from iron-mediated oxidative damage [#5, #0]. The protein adopts a conserved fold of a six-stranded antiparallel β-sheet flanked by two α-helices [#1], presenting a highly anionic surface that binds both ferrous and ferric iron with weak, chaperone-like affinity and attenuates Fenton-driven hydroxyl radical production [#2, #3]. Through this iron-binding surface, frataxin acts as an iron-dependent regulator of Fe-S cluster assembly: the bacterial ortholog CyaY binds the cysteine desulfurase IscS to slow cluster formation on the IscU scaffold by modulating IscS enzymatic activity, with IscX competing for the same IscS surface to provide iron-concentration-dependent tuning of assembly rate [#0, #4, #7]. Restoring frataxin to FRDA-deficient cells reverses mitochondrial iron accumulation, loss of membrane potential, and reduced Fe-S enzyme (aconitase) activity, while delivery of functional frataxin to deficient neurons and mice restores succinate dehydrogenase activity and reduces apoptotic signaling, directly establishing its role in mitochondrial iron homeostasis and oxidative protection [#5, #18]. In Friedreich ataxia, expanded GAA repeats in FXN intron 1 silence the gene through heterochromatin-like histone marks confined to the locus, blocking the transition from initiation to productive transcriptional elongation, with additional promoter-level initiation deficiency, altered 5-hydroxymethylcytosine and reduced CTCF occupancy, and post-transcriptional repression by miRNAs targeting the FXN 3′-UTR [#11, #12, #16, #14, #15].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established whether the bacterial frataxin ortholog was essential, testing if its structural conservation implied a conserved indispensable iron role.\",\n      \"evidence\": \"Homologous recombination knockout of cyaY in E. coli with iron content and oxidant sensitivity readouts\",\n      \"pmids\": [\"10452520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result under normal conditions did not exclude a redundant or condition-specific role\", \"No biochemical mechanism addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the frataxin fold at atomic resolution, providing the structural framework for interpreting disease mutations and iron binding.\",\n      \"evidence\": \"X-ray crystallography of E. coli CyaY at 1.4 Å\",\n      \"pmids\": [\"10908679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure alone did not assign function\", \"Iron-binding surface not yet mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Placed frataxin causally in mitochondrial iron homeostasis by showing re-expression reverses the deficiency phenotype.\",\n      \"evidence\": \"Stable frataxin transfection of FRDA lymphoblasts with mitochondrial iron, membrane potential, and aconitase/ICDH assays\",\n      \"pmids\": [\"11590127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve direct molecular partners\", \"Whether the defect is primary in Fe-S assembly vs iron sequestration unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Characterized the iron-binding biochemistry and antioxidant behavior, supporting an iron chaperone role and mapping iron to a conserved anionic surface.\",\n      \"evidence\": \"ITC, EPR spin trapping, spectroscopy, ultracentrifugation, and NMR with mutagenesis of CyaY\",\n      \"pmids\": [\"15276847\", \"15530368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Weak affinity left physiological iron donation uncertain\", \"Secondary CyaY sites absent in human frataxin limit direct extrapolation\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Confirmed mitochondrial targeting from the native locus and demonstrated FXN expression is pharmacologically tunable.\",\n      \"evidence\": \"BAC FRDA-EGFP fusion in stable cells with fluorescence localization and pharmacological treatment\",\n      \"pmids\": [\"12516053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of hemin/butyrate upregulation not defined\", \"Reporter context may differ from endogenous regulation\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved whether frataxin activates or inhibits Fe-S assembly by showing CyaY is an iron-dependent inhibitor binding IscS through its iron surface.\",\n      \"evidence\": \"Biochemical/biophysical binding to IscS, cluster formation kinetics, and iron-surface mutagenesis\",\n      \"pmids\": [\"19305405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Inhibitory directionality differs from activating models reported for the human system\", \"In vivo regulatory relevance not established here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Independently confirmed the inhibitory mechanism and localized the effect to IscS enzymatic activity, and separately established that GAA repeats block transcriptional elongation rather than initiation.\",\n      \"evidence\": \"Spectroscopic cluster-formation kinetics on IscU; ChIP-qPCR and GFP reporter with 560 GAA repeats plus pre-mRNA quantification\",\n      \"pmids\": [\"21799759\", \"21745819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of elongation-block vs initiation-block models for the disease locus unresolved\", \"Cluster-type ratio unaffected leaves the precise regulatory output unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the regulatory logic of frataxin in assembly via IscX competition and refined the chromatin and transcriptional basis of FXN silencing.\",\n      \"evidence\": \"Genetic cyaY/iscX epistasis; RNA-seq and ChIP confining heterochromatin to the FXN locus; nascent transcript labeling in a humanized mouse model\",\n      \"pmids\": [\"25430730\", \"26401053\", \"26393353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Initiation-deficiency (YG8sR) vs elongation-block (patient cells) findings not fully reconciled\", \"Whether bacterial IscX competition has a eukaryotic equivalent unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified post-transcriptional and epigenetic layers of FXN repression beyond the GAA chromatin defect.\",\n      \"evidence\": \"Luciferase 3′-UTR reporters with cohort sequencing (miR-124); MethylScreen and CTCF ChIP in FRDA cerebellum/heart\",\n      \"pmids\": [\"23382970\", \"24023969\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of miRNA vs chromatin silencing to total deficit unquantified\", \"Functional consequence of 5hmC/CTCF loss on transcription not directly tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated structural basis of iron-driven oligomerization and that exogenous functional frataxin can rescue mitochondrial enzyme and survival defects.\",\n      \"evidence\": \"DLS/SAXS/EM/cross-linking MS of human FXN81-210 and CyaY; TAT-MTScs-FXN delivery to DRG neurons and FRDA mice with enzyme and apoptosis readouts\",\n      \"pmids\": [\"29200434\", \"28980774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of human frataxin oligomers uncertain given low stability\", \"Delivery rescue durability and dosing not fully resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended the miRNA regulatory network controlling FXN levels.\",\n      \"evidence\": \"miRNAseq/RNAseq, luciferase, qRT-PCR, immunoblot, and ZFN GAA excision for miR-224-5p\",\n      \"pmids\": [\"32291635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance to neuronal/cardiac tissue not established\", \"Interaction with chromatin-level silencing unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the human frataxin–NFS1/ISCU regulatory interaction (inhibitory vs activating) and the relative weight of transcriptional, chromatin, and miRNA mechanisms combine to determine tissue-specific frataxin deficit remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct human FXN-NFS1-ISCU mechanism not biochemically resolved in this corpus\", \"Quantitative apportioning of silencing mechanisms missing\", \"Tissue-selectivity of pathology mechanistically unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 7]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [2, 3, 5]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [5, 13, 18]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 12, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 12, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"IscS/NFS1\", \"IscU/ISCU\", \"IscX\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}